* LifeMD Inc LFMD.OQ reported a quarterly adjusted loss
of 26
cents per share for the quarter ended in September. The mean
expectation of two analysts for the quarter was for a loss of 28
cents per share.
* Revenue rose 25.9% to $31.41 million from a year ago;
analysts
expected $31.84 million.
* LifeMD Inc's reported EPS for the quarter was a loss of 26
cents.
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company.
* LifeMD Inc shares had risen by 2.0% this quarter and
lost 48.1%
so far this year.
* The company reported a quarterly loss of $8.06 million.
* Wall Street's median 12-month price target for LifeMD Inc
is
$8.00
* The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 2 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell."
This summary was machine generated from Refinitiv data November
10 at 10:56 p.m. All figures in US dollars unless otherwise
stated. QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Sep. 30 2022 -0.28 -0.26 Beat
Jun. 30 2022 -0.35 -0.45 Missed
Mar. 31 2022 -0.36 -0.46 Missed
Dec. 31 2021 -0.42 -0.62 Missed